Spotlight on opicapone as an adjunct to levodopa in Parkinson’s disease: design, development and potential place in therapy

Parkinson’s disease (PD) is a progressive, chronic, neurodegenerative disease characterized by rigidity, tremor, bradykinesia and postural instability secondary to dopaminergic deficit in the nigrostriatal system. Currently, disease-modifying therapies are not available, and levodopa (LD) treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Annus, Ádám, Vécsei, László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234693/
https://www.ncbi.nlm.nih.gov/pubmed/28123288
http://dx.doi.org/10.2147/DDDT.S104227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234693/
https://www.ncbi.nlm.nih.gov/pubmed/28123288
http://dx.doi.org/10.2147/DDDT.S104227

Ejemplares similares